HIPRAVIAR-S ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΟΦΘΑΛΜΟΡΙΝΙΚΟ ΕΝΑΙΩΡΗΜΑ/ ΓΙΑ ΧΟΡΗΓΗΣΗ ΜΕ ΠΟΣΙΜΟ ΝΕΡΟ
HIPRAVIAR-S ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΟΦΘΑΛΜΟΡΙΝΙΚΟ ΕΝΑΙΩΡΗΜΑ/ ΓΙΑ ΧΟΡΗΓΗΣΗ ΜΕ ΠΟΣΙΜΟ ΝΕΡΟ
Authorised
- Newcastle disease virus, strain La Sota, Live
Product identification
Medicine name:
HIPRAVIAR-S ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΟΦΘΑΛΜΟΡΙΝΙΚΟ ΕΝΑΙΩΡΗΜΑ/ ΓΙΑ ΧΟΡΗΓΗΣΗ ΜΕ ΠΟΣΙΜΟ ΝΕΡΟ
Active substance:
- Newcastle disease virus, strain La Sota, Live
Target species:
-
Chicken
Route of administration:
-
Oral use
-
Nasal use
-
Coarse spray
Product details
Active substance and strength:
-
Newcastle disease virus, strain La Sota, Live3162280.00/50% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Meat and offal0day
-
-
-
Nasal use
-
Chicken
-
Meat and offal0day
-
-
-
Coarse spray
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 97088/19-10-2021/K-0078101
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 14/06/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 14/06/2023